NCI Cancer Bulletin: (The GOG Rare Tumor Committee) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, January 12, 2011

NCI Cancer Bulletin: (The GOG Rare Tumor Committee)



Comparing First-Line Therapies for Mucinous Ovarian or Fallopian Tube Cancer

Name of the Trial
Phase III Study of Carboplatin and Paclitaxel with Versus without Bevacizumab Compared to Oxaliplatin and Capecitabine with Versus without Bevacizumab as First-Line Therapy in Patients with Newly Diagnosed Stage II-IV or Recurrent Stage I Mucinous Epithelial Ovarian or Fallopian Tube Cancer (GOG-0241). See the protocol summary.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.